N/A
N=123
Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis
Maxillary Sinusitis
Bottom Line
View on ClinicalTrials.gov: NCT01032174 ↗Enrolled (actual)
123
Serious AEs
0.0%
Results posted
Mar 2012
Primary outcome: Primary: Percentage of Participants With Response of Very Convenient or Somewhat Convenient — 100.0; 72.9 Percentage of Participants — p=<0.0001
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Azithromycin SR (Drug); Amoxiclav 1000 mg (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Pfizer
- Primary completion
- Mar 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Response of Very Convenient or Somewhat Convenient |
100.0; 72.9 | <0.0001 sig |
| SECONDARY Percent Compliance With Prescribed Treatment Regimen |
100.00; 99.00 | 0.0568 |
| SECONDARY Percentage of Participants Who Were 100 Percent Compliant With Prescribed Treatment Regimen |
100.0; 91.7 | 0.0682 |
Summary
The purpose of this study is to compare compliance between patients with Acute Bacterial Sinusitis (ABS) treated with Azithromycin SR 2.0 g single dose orally and those treated with Amoxiclav - 1000 mg twice daily 10 days for the empiric treatment of ABS in outpatient clinic practice.
Eligibility Criteria
Inclusion Criteria
- Male or nor pregnant or lactating female outpatients, 18 years of age or older.
- A clinical diagnosis of acute bacterial uncomplicated maxillary sinusitis as demonstrated by presence of the following signs and symptoms for a minimum duration of 7-10 days:
- Facial pain, pressure and/or tightness over one or both maxillary sinuses, and/or pain in one or both maxillary areas that worsens with movement or percussion, and
- Presence of one or more of the following signs:
i.purulent nasal discharge ii.purulent drainage in the posterior pharynx iii.purulent discharge from the maxillary sinus orifice
- A sinus X-ray (Water's view) confirming the clinical diagnosis of maxillary sinusitis. At least one of the following must be documented in one or both maxillary sinuses on radiologic examination:
- complete or partial opacification
- an air/fluid level
Two or more of the following:
- fever, as defined by temperature: >38ºC
- leukocytosis [White Blood Cell (WBC) >10, 000/mm3 or >15% band forms], ECR;
- headache,
- nasal congestion and post nasal drainage.
Exclusion Criteria
- Known or suspected hypersensitivity or intolerance or contraindications to Azithromycin, Amoxiclav according to LPDs, pregnant or lactating women.
Data sourced from ClinicalTrials.gov (NCT01032174). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.